Keybank National Association OH Acquires New Stake in Phreesia, Inc. $PHR

Keybank National Association OH acquired a new stake in shares of Phreesia, Inc. (NYSE:PHR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,495 shares of the company’s stock, valued at approximately $441,000.

A number of other hedge funds also recently bought and sold shares of PHR. KBC Group NV purchased a new stake in Phreesia during the first quarter valued at $74,000. Farther Finance Advisors LLC boosted its stake in shares of Phreesia by 9,375.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after acquiring an additional 3,000 shares during the last quarter. CWM LLC boosted its stake in shares of Phreesia by 994.9% during the 1st quarter. CWM LLC now owns 4,040 shares of the company’s stock worth $103,000 after acquiring an additional 3,671 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Phreesia by 53.0% during the 1st quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock worth $137,000 after acquiring an additional 1,825 shares during the last quarter. Finally, Entropy Technologies LP purchased a new position in shares of Phreesia during the 1st quarter worth $202,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on PHR. Mizuho began coverage on shares of Phreesia in a research note on Wednesday, August 27th. They set an “outperform” rating and a $36.00 price target on the stock. KeyCorp dropped their price target on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. DA Davidson upgraded shares of Phreesia to a “strong-buy” rating in a research note on Monday, September 8th. Truist Financial lifted their price target on shares of Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a research note on Friday, September 5th. Finally, Piper Sandler lifted their price target on shares of Phreesia from $33.00 to $34.00 and gave the stock an “overweight” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $33.85.

Insiders Place Their Bets

In other Phreesia news, CFO Balaji Gandhi sold 4,183 shares of the business’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total value of $97,380.24. Following the sale, the chief financial officer owned 99,125 shares in the company, valued at $2,307,630. The trade was a 4.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Allison C. Hoffman sold 1,241 shares of the business’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $22.36, for a total transaction of $27,748.76. Following the completion of the sale, the general counsel owned 135,737 shares in the company, valued at approximately $3,035,079.32. The trade was a 0.91% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 92,244 shares of company stock worth $2,680,720. 5.50% of the stock is owned by corporate insiders.

Phreesia Stock Performance

NYSE:PHR opened at $22.57 on Wednesday. The company has a current ratio of 2.12, a quick ratio of 2.12 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $32.76. The stock has a 50-day moving average price of $24.75 and a 200 day moving average price of $25.93. The stock has a market capitalization of $1.35 billion, a P/E ratio of -53.74 and a beta of 0.68.

Phreesia (NYSE:PHR) last released its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The firm had revenue of $117.26 million during the quarter, compared to analysts’ expectations of $116.39 million. During the same quarter last year, the business posted ($0.03) earnings per share. The firm’s revenue was up 14.9% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. Equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.